DSS, Inc.'s Form 4 filing
Impact Biomedical Inc. (IBO) · filed Mar 28, 2025
- Accession no.
- 0001641172-25-001312
- Filed
- Mar 28, 2025
- Trade date
- Mar 21-27, 2025
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions. Open-market sales total $1.95M. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| DSS, Inc.CIK 0000771999 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2025 | Common Stock | SSaleDisposed | −166,600 | $3.30 | −$549,780 | 0 | Indirect | |
| Mar 21, 2025 | Common Stock | SSaleDisposed | −166,600 | $3.30 | −$549,780 | 0 | Indirect | |
| Mar 21, 2025 | Common Stock | SSaleDisposed | −166,600 | $3.30 | −$549,780 | 1,178,882 | Indirect | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −48,281 | $3.13 | −$151,119.53 | 1,109,339 | Direct | |
| Mar 26, 2025 | Common Stock | SSaleDisposed | −9,858 | $3.15 | −$31,052.7 | 1,099,481 | Direct | |
| Mar 27, 2025 | Common Stock | SSaleDisposed | −47,681 | $2.50 | −$119,202.5 | 1,051,800 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.